Samsung Pharm (001360) — Working Capital to Net Assets Ratio
Samsung Pharm (001360) has a Working Capital to Net Assets ratio of 12.1% as of September 2025. Working capital of ₩21.75 Billion (current assets of ₩62.02 Billion minus current liabilities of ₩40.26 Billion) is measured against net assets of ₩180.09 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See 001360 net asset quality index to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Samsung Pharm Working Capital to Net Assets (2012–2024)
This chart shows how Samsung Pharm's Working Capital to Net Assets ratio has evolved across 12 annual periods from 2012 to 2024. As of September 2025, the ratio stands at 12.1%, reflecting working capital of ₩21.75 Billion against net assets of ₩180.09 Billion KRW. Check 001360 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Samsung Pharm (2012–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Samsung Pharm from 2012 to 2024, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Samsung Pharm market capitalisation.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 26.9% | ₩28.44 Billion | ₩105.86 Billion | ₩47.01 Billion | ₩18.56 Billion | ▲ +5.4 pp |
| 2023 | 21.4% | ₩16.64 Billion | ₩77.58 Billion | ₩29.45 Billion | ₩12.82 Billion | ▼ -32.5 pp |
| 2022 | 53.9% | ₩55.34 Billion | ₩102.59 Billion | ₩69.57 Billion | ₩14.23 Billion | ▼ 0.0 pp |
| 2021 | 54.0% | ₩68.69 Billion | ₩127.27 Billion | ₩85.39 Billion | ₩16.70 Billion | ▲ +41.6 pp |
| 2020 | 12.4% | ₩15.12 Billion | ₩121.92 Billion | ₩65.31 Billion | ₩50.19 Billion | ▼ -15.0 pp |
| 2019 | 27.4% | ₩39.12 Billion | ₩142.83 Billion | ₩61.39 Billion | ₩22.27 Billion | ▼ -12.1 pp |
| 2018 | 39.5% | ₩51.96 Billion | ₩131.66 Billion | ₩76.65 Billion | ₩24.69 Billion | ▲ +30.1 pp |
| 2017 | 9.4% | ₩8.80 Billion | ₩93.87 Billion | ₩60.98 Billion | ₩52.18 Billion | ▼ -4.2 pp |
| 2016 | 13.6% | ₩11.20 Billion | ₩82.38 Billion | ₩47.71 Billion | ₩36.51 Billion | ▼ -72.2 pp |
| 2015 | 85.8% | ₩39.67 Billion | ₩46.24 Billion | ₩65.50 Billion | ₩25.82 Billion | ▲ +96.8 pp |
| 2014 | -11.0% | ₩-2.56 Billion | ₩23.29 Billion | ₩25.91 Billion | ₩28.47 Billion | ▼ -101.3 pp |
| 2012 | 90.3% | ₩31.36 Billion | ₩34.71 Billion | ₩68.78 Billion | ₩37.42 Billion | — |